Factors Affecting Phase I Stereoselective Biotransformation of Chiral Polychlorinated Biphenyls by Rat Cytochrome P-450 2B1 Isozyme
- 24 August 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 45 (19) , 8298-8305
Abstract
In vitro incubations of rat cytochrome P-450 (CYP) 2B1 isozyme with three chiral polychlorinated biphenyl (PCB) congeners (PCBs 45, 95, and 132) were performed to investigate factors affecting phase I stereoselective biotransformation. Rat CYP2B1 preferentially biotransformed the second-eluting atropisomers of PCBs 45 and 95 at low substrate concentration ranges (≤15 μM). Biotransformation competition by different congeners was also observed, with increasing competition at higher chlorination. Competition decreased the biotransformation rates of each congener stereoselectively, affecting atropisomeric composition. No atropisomeric enrichment was observed for PCB 132 upon incubation of the racemate. However, under the same conditions, significant differences in biotransformation kinetics were observed in individual atropisomer incubations, indicating that (+)-PCB 132 and (-)-PCB 132 were competitively biotransformed. Homology modeling and docking studies suggested that each atropisomer had different interactions with rat CYP2B1 and could dock with the isozyme at different locations. This is one possible explanation for stereoselective biotransformation and competition of chiral PCBs at the molecular level. Our results suggest that the lack of predictive capability for stereoselectivity of PCBs and other chiral pollutants in biota may be due to competitive and/or inhibitory activities of different substrates, including individual enantiomers of the same compound.Keywords
This publication has 44 references indexed in Scilit:
- Chiral Polychlorinated Biphenyl Transport, Metabolism, and Distribution: A ReviewEnvironmental Science & Technology, 2009
- Modelling of Bet v 1 Binding to LipidsScandinavian Journal of Immunology, 2009
- Enantiomeric Specificity of (−)-2,2′,3,3′,6,6′-Hexachlorobiphenyl toward Ryanodine Receptor Types 1 and 2Chemical Research in Toxicology, 2008
- The SWISS-MODEL Repository and associated resourcesNucleic Acids Research, 2008
- 2,2′,3,3′,6,6′-Hexachlorobiphenyl (PCB 136) Atropisomers Interact Enantioselectively with Hepatic Microsomal Cytochrome P450 EnzymesChemical Research in Toxicology, 2008
- Differential inhibition of hepatic microsomal alkoxyresorufin O-dealkylation activities by tetrachlorobiphenylsChemico-Biological Interactions, 2007
- Drug disposition in three dimensions: an update on stereoselectivity in pharmacokineticsBiopharmaceutics & Drug Disposition, 2006
- The SWISS-MODEL workspace: a web-based environment for protein structure homology modellingBioinformatics, 2005
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Assessment of protein models with three-dimensional profilesNature, 1992